about
Recent advances using zebrafish animal models for muscle disease drug discoveryAAV.Dysferlin Overlap Vectors Restore Function in Dysferlinopathy Animal ModelsCD4+ cells, macrophages, MHC-I and C5b-9 involve the pathogenesis of dysferlinopathyPlasma Membrane Repair: A Central Process for Maintaining Cellular Homeostasis.Dysferlin is essential for endocytosis in the sea star oocyte.New developments in exon skipping and splice modulation therapies for neuromuscular diseases.Muscle-Derived Proteins as Serum Biomarkers for Monitoring Disease Progression in Three Forms of Muscular Dystrophy.Neuromuscular electrical stimulation promotes development in mice of mature human muscle from immortalized human myoblasts.Structure-Based Designed Nano-Dysferlin Significantly Improves Dysferlinopathy in BLA/J Mice.Giant scaffolding protein AHNAK1 interacts with β-dystroglycan and controls motility and mechanical properties of Schwann cells.The C2 domains of otoferlin, dysferlin, and myoferlin alter the packing of lipid bilayers.Novel duplication mutation of the DYSF gene in a Pakistani family with Miyoshi Myopathy.Increased non-HDL cholesterol levels cause muscle wasting and ambulatory dysfunction in the mouse model of LGMD2B.Serum exosomes can restore cellular function in vitro and be used for diagnosis in dysferlinopathy.Identification of Novel Antisense-Mediated Exon Skipping Targets in DYSF for Therapeutic Treatment of Dysferlinopathy
P2860
Q28551915-CC8B148C-AF5A-4247-9813-211AF26E41C5Q35204883-F82C3FCF-9360-48C6-9452-937C716ED726Q35632288-3B952941-5A46-4480-8632-9D25A0F71AE9Q36240722-51E0A25C-255B-4E21-BA05-6864D9670164Q37695556-295F8216-8420-43C2-BA87-CEC32395E1C9Q38195295-5B5D1D07-1A6B-4E90-B750-1B94B3D87834Q38302852-495985C9-8784-4728-BE2B-01BEF5BD2CABQ38658555-84B69650-C856-43B1-9FC1-2D307A798917Q38718597-D5113BF4-C022-451C-A204-5583D59FD4D1Q42458390-F24B49D2-0EC2-4A69-A027-17C8AC478686Q42908556-A9748E3C-4226-4338-A758-446FCF5F984DQ47199699-7C193076-B5BF-4AEC-B799-BC7F9C75AD38Q47413106-5C4D895D-E403-42AE-87E6-A929B812823FQ55139802-FAC19BDE-96FE-4062-9F54-38C93DA0F4C8Q59129603-EADA923A-C9AF-493F-BCE2-18BB55668E32
P2860
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Dysferlin and animal models for dysferlinopathy
@ast
Dysferlin and animal models for dysferlinopathy
@en
type
label
Dysferlin and animal models for dysferlinopathy
@ast
Dysferlin and animal models for dysferlinopathy
@en
prefLabel
Dysferlin and animal models for dysferlinopathy
@ast
Dysferlin and animal models for dysferlinopathy
@en
P2093
P2860
P356
P1476
Dysferlin and animal models for dysferlinopathy
@en
P2093
Jyoji Yamate
Kinji Kobayashi
Mitsuru Kuwamura
Takeshi Izawa
P2860
P304
P356
10.1293/TOX.25.135
P577
2012-06-01T00:00:00Z